Keith M. Gottesdiener
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Keith M. Gottesdiener
Earlier roles on record: CEO at Rhythm Pharmaceuticals, Inc. (RYTM) until March 27, 2020. The proxy statement of Rhythm Pharmaceuticals, Inc. reports total compensation of $3,449,169 for Keith M. Gottesdiener in fiscal 2020, including a base salary of $142,906. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2020-03-27
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Rhythm Pharmaceuticals, Inc. (RYTM) | Former President and Chief Executive Officer | $142,906 | $3,449,169 |
| 2019 | Rhythm Pharmaceuticals, Inc. (RYTM) | Former President and Chief Executive Officer | $525,934 | $4,937,042 |
| 2018 | Rhythm Pharmaceuticals, Inc. (RYTM) | M.D. , Former President and Chief Executive Officer | $505,519 | $3,539,804 |
Recent activity
No call appearances or filed executive changes recorded yet.